Protection from gastrointestinal diseases with the use of probiotics

American Journal of Clinical Nutrition

Volumn 73, Issue 2 SUPPL., 2001, Pages

  Marteau, P R ^a   De Vrese, M ^a   Cellier, C J ^a   Schrezenmeir, J ^a  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

Antibiotic associated diarrhea; Bifidobacteria; Colon cancer; Gastroenteritis; Inflammatory bowel disease; Intestinal flora; Intestinal infections; Lactobacilli; Probiotics; Traveler's diarrhea

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CLINDAMYCIN; ERYTHROMYCIN; NEOMYCIN; PROBIOTIC AGENT; TETRACYCLINE DERIVATIVE; TUBERCULOSTATIC AGENT;

ADULT; BACTERIAL COLONIZATION; BIFIDOBACTERIUM; CHILD; CLINICAL TRIAL; COLON CANCER; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; ENTEROCOCCUS FAECIUM; GASTROENTERITIS; GASTROINTESTINAL DISEASE; HELICOBACTER PYLORI; HUMAN; LACTOBACILLUS; LACTOBACILLUS RHAMNOSUS; MAJOR CLINICAL STUDY; NONHUMAN; RANDOMIZED CONTROLLED TRIAL; SACCHAROMYCES BOULARDII; TRAVELLER DIARRHEA; TREATMENT OUTCOME;

BACTERIA (MICROORGANISMS); BIFIDOBACTERIUM; CLOSTRIDIUM DIFFICILE; ENTEROCOCCUS FAECIUM; HELICOBACTER PYLORI; LACTOBACILLUS; LACTOBACILLUS RHAMNOSUS; POSIBACTERIA; ROTAVIRUS; SACCHAROMYCES BOULARDII;

EID: 0035150528     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/73.2.430s     Document Type: Conference Paper

References (92)

1. Probiotics in man and animal
2. Fate and effects of some transiting microorganisms in the human gastrointestinal tract
3. Probiotics - Compensation for lactase insufficiency
4. Effect of the microbial lactase activity in yogurt on the intestinal absorption of lactose: An in vivo study in lactase-deficient humans
5. Intestinal nitrogen and electrolyte movements following fermented milk ingestion in human
6. Management of lactose maldigestion by consuming milk containing lactobacilli
7. Tolerance and absorption of lactose from milk and yogurt during short-bowel syndrome in humans
8. Do patients with short bowel syndrome need a lactose free diet?
9. Enzyme substitution therapy with the yeast Saccharomyces cerevisiae in congenital sucrase-isomaltase deficiency
10. Prophylaxis against ampicillin-associated diarrhea with a lactobacillus preparation
11. Exogenous lactobacilli fed to man. Their fate and ability to prevent diarrheal disease
12. Effect of Lactobacillus acidophilus on antibiotic-associated gastrointestinal morbidity: A prospective randomized trial
13. A controlled clinical study on Streptococcus faecium preparation for the prevention of side reactions during long-term antibiotic treatments
14. Double-blind report on the efficacy of lactic acid-producing Enterococcus SF68 in the prevention of antibiotic-associated diarrhoea and in the treatment of acute diarrhoea
15. Yoghurt with Bifidobacterium longum reduces erythromcyin-induced gastrointestinal effects
16. Effect of Lactobacillus GG yoghurt in prevention of antibiotic associated diarrhoea
17. Successful probiotic therapy of chronic recurrent abdominal pain in children
18. Effects of supplements of Bifidobacterium longum and Lactobacillus acidophilus on the intestinal microbiota during administration of clindamycin
19. Essais cliniques contrôlés en double insu de l'Ultralevure lyophylisée
20. Prevention of antibiotic associated diarrhea by Saccharomyces boulardii: A prospective study
21. Prevention of beta-lactam-associated diarrhea by Saccharomyces boulardii compared with placebo
22. Le traitement par l'Ultralevure des troubles intestinaux secondaires à l'antibiothérapie. Etude en double aveugle et étude clinique simple
23. Biotherapeutic agents. A neglected modality for the treatment and prevention of selected intestinal and vaginal infections
24. Antibiotic-associated diarrhea: Treatments by living organisms given by the oral route (probiotics)
25. A double-blind, placebo controlled study of the efficacy of Lactinex in the prophylaxis of amoxicillin-induced diarrhea
26. Controlled trial of orally administered lactobacilli in acute infantile diarrhea
27. Emploi des ferments lactiques dans la gastroentérite non bacterienne
28. A double-blind, controlled trial of bioflorin (Streptococcus faecium SF68) in adults with acute diarrhea due to Vibrio cholerae and enterotoxigenic Escherichia coli
29. A human Lactobacillus strain (Lactobacillus casei sp strain GG) promotes recovery from acute diarrhea in children
30. Enhancement of the circulating antibody secreting cell response in human diarrhea by a human Lactobacillus strain
31. Lactic acid bacteria in the treatment of acute rotavirus gastroenteritis
32. Oral bacteriotherapy for viral gastroenteritis
33. Efficacy of lactobacillus preparation biolactis powder in children with rotavirus enteritis
34. Lactobacillus GG promotes recovery from acute nonbloody diarrhea in Pakistan
35. Lactobacillus GG and acute diarrhea in young children in the tropics
36. Oral bacterial therapy reduces the duration of symptoms and of viral excretion in children with mild diarrhea
37. A trial in the Karelian Republic of oral rehydration and Lactobacillus GG for treatment of acute diarrhoea
38. Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: A multicenter European trial
39. A controlled double blind study of SF68 strain as a new biological preparation for the treatment of diarrhea in pediatrics
40. A double blind comparison of two different treatments for acute enteritis in adults
41. Efficacy of SF 68 in the treatment of acute diarrhea. A placebo-controlled trial
42. Traitement des diarrhées aigues infantiles: Essai contrôlé de Saccharomyces boulardii
43. Bacteriotherapy with Lactobacillus reuteri in rotavirus gastroenteritis
44. Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diahrroea and shedding of rotavirus
45. Viable versus inactivated Lactobacillus strain GG in acute rotavirus diarrhoea
46. Etude controlée du Lactéol fort contre placebo et contre produit de référence dans les diarrhées aigues de I'adulte
47. Probiotics and intestinal infections
48. The effect of Lactobacillus acidophilus administration upon the survival of Salmonella in randomly selected human carriers
49. The effects of Bifidobacterium breve administration on Campylobacter enteritis
50. Successful treatment of relapsing Clostridium difficile colitis with Lactobacillus GG
51. Prevention of further recurrence of Clostridium difficile colitis with Saccharomyces boulardii
52. Saccharomyces boulardii for Clostridium difficile associated enteropathies in infants
53. Treatment of recurrent Clostridium difficile colitis with vancomycin and Saccharomyces boulardii
54. Treatment of recurrent Clostridium difficile colitis with Lactobacillus GG
55. Treatment of relapsing C. difficile diarrhea with Lactobacillus GG
56. Experience with live Lactobacillus plantarum 299v: A promising adjunct in the management of recurrent Clostridium difficile infection
57. A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile
58. Lactobacillus GG supplementation does not reduce faecal colonization of Klebsiella oxytoca in preterm children
59. In vitro inhibition of Helicobacter pylori NCTC 11637 by organic acids and lactic acid bacteria
60. In vivo Helicobacter pylori clearance failure with Lactobacillus acidophilus
61. Effect of whey-based culture supernatant of Lactobacillus acidophilus (johnsonii) La 1 on Helicobacter pylori infection in humans
62. Guidelines on acute infectious diarrhea in adults. The Practice Parameters Committee of the American College of Gastroenterology
63. Prevention and treatment of travelers' diarrhea
64. Effect of a lactobacilli preparation on traveler's diarrhea. A randomized, double blind clinical trial
65. Lactobacilli to prevent traveler's diarrhea?
66. Prophylactic efficacy of lactobacilli on traveler's diarrhea
67. Prophylaxe des Reisediarrhöe mit Saccharomyces boulardii
68. Prevention of traveler's diarrhea by Lactobacillus GG
69. Efficacy of Lactobacillus GG as a diarrheal preventive in travelers
70. Traitement des colopathies fonctionnelles-Essai en double aveugle de I'ultra-levure
71. Treatment of irritable bowel syndrome with Lacteol fort: A randomized, double-blind, cross-over trial
72. Complementary medicine in non-ulcer dyspepsia: Is alternative medicine a real alternative? A randomized placebo-controlled double-blind clinical trial with two probiotic agents - Hylac® and Hylac® forte
73. Prévention par Saccharomyces boulardii des diarrhées de l'alimentation entérale à débit continu
74. Intérêt de Saccharomyces boulardii dans la tolérance digestive de la nutrition entérale à débit continu chez le brûlé
75. Saccharomyces boulardii prevents diarrhea in critically ill tube-fed patients. A multicenter, randomized, double-blind placebo-controlled trial
76. Biomodulation of the toxic and nutritional effects of small bowel bacterial overgrowth in end-stage kidney disease using freeze-dried Lactobacillus acidophilus
77. Treatment strategies for small bowel bacterial overgrowth in short bowel syndrome
78. Antibiotic efficacy in small intestinal bacterial overgrowth-related chronic diarrhea: A crossover, randomized trial
79. Preservation of intestinal integrity during radiotherapy using live Lactobacillus acidophilus cultures
80. Evaluation of Saccharomyces boulardii for patients with HIV-related chronic diarrhoea and healthy volunteers receiving antifungals
81. Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease
82. Pouchitis: Result of microbial imbalance?
83. The effect of exogenous administration of Lactobacillus reuteri R2LC and oat fiber on acetic acid-induced colitis in the rat
84. The effects of Lactobacillus strains and oat fiber on methotrexate-induced enterocolitis in rats
85. Promotion of IgA immune response in patients with Crohn's disease by oral bacteriotherapy with Lactobacillus GG
86. Therapeutic effects of Saccharomyces boulardii on mild residual symptoms in a stable phase of Crohn's disease with special respect to chronic diarrhea - A pilot study
87. Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis
88. Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: A randomised trial
89. Probiotics in inflammatory bowel disease: New insight to pathogenesis or a possible therapeutic alternative?
90. Protective role of probiotics and prebiotics in colon cancer
91. The role of lactic acid bacteria in colon cancer prevention